Abbisko Therapeutics Co., an oncology-focused Chinese biotech company, is planning a Hong Kong initial public offering that could raise about $250 million, according to people familiar with the matter …
( read original story …)
ADVERTISEMENT
Abbisko Therapeutics Co., an oncology-focused Chinese biotech company, is planning a Hong Kong initial public offering that could raise about $250 million, according to people familiar with the matter …
( read original story …)